359 related articles for article (PubMed ID: 17525657)
21. Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.
Munir WM; Rosenfeld SI; Udell I; Miller D; Karp CL; Alfonso EC
Cornea; 2007 Jun; 26(5):621-4. PubMed ID: 17525664
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis.
Yang YN; Bauer D; Wasmuth S; Steuhl KP; Heiligenhaus A
Exp Eye Res; 2003 Aug; 77(2):227-37. PubMed ID: 12873454
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study.
Agarwal PK; Roy P; Das A; Banerjee A; Maity PK; Banerjee AR
Indian J Ophthalmol; 2001 Sep; 49(3):173-6. PubMed ID: 15887725
[TBL] [Abstract][Full Text] [Related]
24. Fusarium keratitis 3 weeks after healed corneal cross-linking.
Garcia-Delpech S; Díaz-Llopis M; Udaondo P; Salom D
J Refract Surg; 2010 Dec; 26(12):994-5. PubMed ID: 20795586
[TBL] [Abstract][Full Text] [Related]
25. Effect of fluoroquinolones on the expression of matrix metalloproteinase in debrided cornea of rats.
Sharma C; Velpandian T; Baskar Singh S; Ranjan Biswas N; Bihari Vajpayee R; Ghose S
Toxicol Mech Methods; 2011 Jan; 21(1):6-12. PubMed ID: 21058936
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of succinylated collagen bandage lenses in corneal healing by the expression of matrix metalloproteinases (MMP-2 and MMP-9) in tear fluid.
Hadassah J; Bhuvaneshwari N; Rao U; Sehgal PK
Ophthalmic Res; 2009; 42(2):64-72. PubMed ID: 19478544
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase distribution during early corneal wound healing.
Mulholland B; Tuft SJ; Khaw PT
Eye (Lond); 2005 May; 19(5):584-8. PubMed ID: 15332107
[TBL] [Abstract][Full Text] [Related]
28. Experimental keratomycosis in a mouse model.
Wu TG; Wilhelmus KR; Mitchell BM
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):210-6. PubMed ID: 12506077
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinases during experimental Candida albicans keratitis.
Yuan X; Mitchell BM; Wilhelmus KR
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):737-42. PubMed ID: 19171647
[TBL] [Abstract][Full Text] [Related]
30. Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis.
Zhang H; Li C; Baciu PC
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):955-62. PubMed ID: 11923234
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic spectrum of fungal keratitis and specific identification of Fusarium solani.
He D; Hao J; Zhang B; Yang Y; Song W; Zhang Y; Yokoyama K; Wang L
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2804-8. PubMed ID: 21273551
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
Liu X; Han Q; Sun R; Li Z
Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903
[TBL] [Abstract][Full Text] [Related]
33. Effects of antiproteolytic agents on corneal epithelial viability and matrix metalloproteinase-2 and metalloproteinase-9 activity in alkali-burned corneas of rats.
Piso DY; Ribeiro AP; Silva ML; Guimarães PJ; Morales A; Martins BC; Padua IM; Renzo R; Andrade AL; Uscátegui RR; Laus JL
Vet Ophthalmol; 2014 Jan; 17(1):23-31. PubMed ID: 23433350
[TBL] [Abstract][Full Text] [Related]
34. Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury.
Ranasinghe HS; Williams CE; Christophidis LJ; Mitchell MD; Fraser M; Scheepens A
Neuroscience; 2009 Jan; 158(2):732-44. PubMed ID: 18809469
[TBL] [Abstract][Full Text] [Related]
35. Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection.
Gutierrez FR; Lalu MM; Mariano FS; Milanezi CM; Cena J; Gerlach RF; Santos JE; Torres-Dueñas D; Cunha FQ; Schulz R; Silva JS
J Infect Dis; 2008 May; 197(10):1468-76. PubMed ID: 18444803
[TBL] [Abstract][Full Text] [Related]
36. [Expression of substance P in experimental fungal keratitis].
Zhao GQ; Wang X; Hu LT; Lin J; Che CY; Jiang N
Zhonghua Yan Ke Za Zhi; 2011 May; 47(5):443-50. PubMed ID: 21756748
[TBL] [Abstract][Full Text] [Related]
37. Clinical features and outcomes of Fusarium keratitis associated with contact lens wear.
Ng AS; Lau WW; Yu DK; Wong CC; Chan CW
Eye Contact Lens; 2008 Mar; 34(2):113-6. PubMed ID: 18327048
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of topical caspofungin in experimental fusarium keratitis.
Ozturk F; Yavas GF; Kusbeci T; Cetinkaya Z; Inan UU; Ermis SS; Kiraz N
Cornea; 2007 Jul; 26(6):726-8. PubMed ID: 17592325
[TBL] [Abstract][Full Text] [Related]
39. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
[TBL] [Abstract][Full Text] [Related]
40. Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice.
Samolov B; Steen B; Seregard S; van der Ploeg I; Montan P; Kvanta A
Exp Eye Res; 2005 Feb; 80(2):159-66. PubMed ID: 15670794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
